Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Cell adhesion molecules (CAMs) (mmu04514)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
14927508
3
KLA  ATP  ATP+KLA
 149275083 Unknown KLA .74 .68 .68 .77 .71 .85 .69
ATP .85 .69 1.26 .89 .89 1.26 .64
KLA/ATP .64 .63 1.07 .96 1.39 1.07 .82
4930468A
15Rik
KLA  ATP  ATP+KLA
 AK015525 adult male testis cDNA, RIKEN full-length enriched library, clone:4930468A15 product:hypothetical protein, full insert sequence [AK015525] KLA .97 1.00 1.03 .98 1.02 1.01 1.02
ATP 1.03 .97 1.05 1.02 .99 .98 .98
KLA/ATP 1.01 1.00 .97 1.01 .95 .98 .96
AK138222
KLA  ATP  ATP+KLA
 AK138222 adult male hypothalamus cDNA, RIKEN full-length enriched library, clone:A230038M12 product:unclassifiable, full insert sequence. [AK138222] KLA 1.04 1.10 1.01 1.04 1.05 .97 .98
ATP .92 1.01 1.08 .91 .96 1.03 1.08
KLA/ATP .96 .92 1.09 1.07 1.02 .92 .99
Alcam
KLA  ATP  ATP+KLA
 NM_009655 activated leukocyte cell adhesion molecule (Alcam), mRNA [NM_009655] KLA 1.82 1.89 2.06 2.12 2.04 1.61 .77
ATP 1.09 1.19 .96 1.09 1.85 2.16 2.19
KLA/ATP 2.05 1.98 1.84 2.23 1.87 1.28 1.84
Cadm1
KLA  ATP  ATP+KLA
 NM_001025600 cell adhesion molecule 1 (Cadm1), transcript variant 4, mRNA [NM_001025600] KLA 1.01 1.08 1.05 1.02 .85 .73 .64
ATP 1.01 1.07 1.16 1.39 1.29 .89 1.23
KLA/ATP 1.13 1.09 1.34 1.36 1.10 .79 .86
Cadm1
KLA  ATP  ATP+KLA
 NM_207675 cell adhesion molecule 1 (Cadm1), transcript variant 1, mRNA [NM_207675] KLA .75 .76 .64 .59 .39 .22 .28
ATP .98 .98 1.04 1.00 .84 .31 .52
KLA/ATP .73 .75 .79 .71 .63 .28 .17
Cadm3
KLA  ATP  ATP+KLA
 NM_053199 cell adhesion molecule 3 (Cadm3), mRNA [NM_053199] KLA .95 1.07 1.03 1.02 1.04 1.00 1.05
ATP 1.03 .94 1.06 1.05 .99 1.02 1.06
KLA/ATP 1.01 .99 .98 1.08 1.06 1.09 1.04
Cd2
KLA  ATP  ATP+KLA
 NM_013486 CD2 antigen (Cd2), mRNA [NM_013486] KLA 1.03 1.01 1.04 1.03 1.00 1.06 .98
ATP .99 1.04 1.13 .98 .96 1.10 1.00
KLA/ATP .94 1.02 1.02 .95 1.04 .93 1.02
Cd22
KLA  ATP  ATP+KLA
 NM_009845 CD22 antigen (Cd22), transcript variant 2, mRNA [NM_009845] KLA .89 .90 .89 .90 .93 1.16 1.81
ATP 1.02 1.06 1.03 1.15 .96 .88 2.26
KLA/ATP .94 .92 .90 .97 .86 .90 1.15
Cd226
KLA  ATP  ATP+KLA
 NM_001039149 CD226 antigen (Cd226), transcript variant 2, mRNA [NM_001039149] KLA 1.01 .94 .97 1.02 .92 .94 .95
ATP .93 .99 .97 .94 .94 1.00 .91
KLA/ATP 1.01 .95 .91 .96 .95 .97 .93
Cd226
KLA  ATP  ATP+KLA
 NM_178687 CD226 antigen (Cd226), transcript variant 1, mRNA [NM_178687] KLA 1.00 1.04 1.04 1.04 1.02 1.00 1.01
ATP 1.00 1.01 .99 .98 1.00 .96 .96
KLA/ATP 1.00 1.06 .98 1.02 .98 .97 .97
Cd274
KLA  ATP  ATP+KLA
 NM_021893 CD274 antigen (Cd274), mRNA [NM_021893] KLA 10.29 9.69 9.00 9.17 8.43 9.37 7.72
ATP 1.01 1.04 1.31 3.41 7.66 9.08 8.09
KLA/ATP 9.28 9.66 11.73 10.97 12.14 11.66 11.75
Cd276
KLA  ATP  ATP+KLA
 NM_133983 CD276 antigen (Cd276), mRNA [NM_133983] KLA .79 .83 .71 .63 .60 .57 .58
ATP 1.04 1.03 .73 .64 .49 .55 1.09
KLA/ATP .84 .81 .61 .57 .48 .52 1.15
Cd28
KLA  ATP  ATP+KLA
 NM_007642 CD28 antigen (Cd28), mRNA [NM_007642] KLA .52 .51 .45 .50 .36 .33 .18
ATP 1.11 1.26 1.08 1.25 1.99 1.42 2.08
KLA/ATP .51 .51 .58 .60 .56 .53 .38
Cd34
KLA  ATP  ATP+KLA
 NM_133654 CD34 antigen (Cd34), transcript variant 2, mRNA [NM_133654] KLA .94 .96 .84 .78 .75 .80 .62
ATP 1.05 1.10 1.57 1.40 1.24 1.07 .70
KLA/ATP .90 .93 1.10 .86 .95 .90 .85
Cd4
KLA  ATP  ATP+KLA
 NM_013488 CD4 antigen (Cd4), mRNA [NM_013488] KLA .99 1.02 1.02 1.03 1.01 1.06 1.09
ATP 1.00 1.02 1.00 1.05 .96 .99 1.04
KLA/ATP 1.03 1.01 1.03 1.06 .97 .98 .98
Cd4
KLA  ATP  ATP+KLA
 X04836 gb|Mouse mRNA for T-cell surface glycoprotein CD4 (L3T4) [X04836] KLA .98 .91 .94 .96 .89 .92 1.03
ATP 1.11 1.07 1.02 .95 .90 .92 .88
KLA/ATP 1.04 1.00 1.01 .97 .90 1.02 .89
Cd40
KLA  ATP  ATP+KLA
 NM_170701 CD40 antigen (Cd40), transcript variant 3, mRNA [NM_170701] KLA 23.87 23.62 23.26 23.98 22.07 17.37 5.34
ATP 1.00 1.01 1.06 2.96 2.65 3.03 1.70
KLA/ATP 22.77 23.79 29.67 28.85 28.08 21.62 13.02
Cd40lg
KLA  ATP  ATP+KLA
 NM_011616 CD40 ligand (Cd40lg), mRNA [NM_011616] KLA 1.03 1.07 1.02 .98 1.06 1.06 1.03
ATP .95 .92 .99 1.06 1.02 1.04 1.07
KLA/ATP 1.00 1.01 .93 1.04 .94 1.01 .98
Cd6
KLA  ATP  ATP+KLA
 NM_001037801 CD6 antigen (Cd6), transcript variant 1, mRNA [NM_001037801] KLA 1.12 1.21 1.15 1.18 1.16 1.22 1.02
ATP .93 1.00 1.13 1.23 1.10 1.27 1.08
KLA/ATP 1.14 1.07 1.21 1.38 1.40 1.14 1.11
Cd6
KLA  ATP  ATP+KLA
 NM_009852 CD6 antigen (Cd6), transcript variant 2, mRNA [NM_009852] KLA .96 1.03 1.03 1.02 1.08 1.01 1.07
ATP 1.00 .98 .95 1.00 .91 1.05 1.07
KLA/ATP .93 1.01 .96 .97 1.03 1.02 1.00
Cd80
KLA  ATP  ATP+KLA
 NM_009855 CD80 antigen (Cd80), mRNA [NM_009855] KLA 2.13 1.91 1.89 1.78 1.29 1.00 .82
ATP .99 1.20 1.98 1.49 1.37 2.40 1.71
KLA/ATP 2.05 2.32 3.09 2.27 1.95 2.89 3.07
Cd86
KLA  ATP  ATP+KLA
 NM_019388 CD86 antigen (Cd86), mRNA [NM_019388] KLA 13.80 14.41 18.21 18.33 17.37 17.26 4.82
ATP 1.02 1.00 2.20 3.64 5.16 6.79 3.81
KLA/ATP 14.80 14.66 18.10 18.96 19.38 20.42 14.21
Cd8a
KLA  ATP  ATP+KLA
 NM_001081110 CD8 antigen, alpha chain (Cd8a), mRNA [NM_001081110] KLA 1.02 1.03 1.04 1.04 1.07 1.03 1.02
ATP 1.01 .98 .99 1.03 1.01 1.00 .99
KLA/ATP 1.02 1.01 1.04 1.03 1.06 1.06 1.00
Cd8b1
KLA  ATP  ATP+KLA
 M17534 gb|Mouse T-cell membrane glycoprotein (Ly-3) mRNA, complete cds. [M17534] KLA 1.04 1.06 1.11 1.12 1.07 1.06 .95
ATP 1.00 1.07 .97 .97 .96 1.05 .98
KLA/ATP .96 1.02 1.07 1.03 1.05 .95 .97
Cd99
KLA  ATP  ATP+KLA
 NM_025584 CD99 antigen (Cd99), mRNA [NM_025584] KLA .96 1.05 1.05 .95 .95 .83 .86
ATP 1.02 1.16 .98 1.46 1.14 1.02 .88
KLA/ATP 1.10 1.10 .88 1.39 .95 1.00 1.11
Cdh1
KLA  ATP  ATP+KLA
 NM_009864 cadherin 1 (Cdh1), mRNA [NM_009864] KLA 1.03 1.03 .99 .94 .95 .97 .99
ATP 1.04 1.06 1.06 .96 .99 1.07 .95
KLA/ATP 1.02 1.07 1.00 .90 .93 .94 .98
Cdh15
KLA  ATP  ATP+KLA
 NM_007662 cadherin 15 (Cdh15), mRNA [NM_007662] KLA 1.22 1.24 1.40 1.36 1.30 1.13 1.11
ATP .97 1.03 1.03 1.70 1.30 1.09 .96
KLA/ATP 1.31 1.40 1.34 1.46 1.35 1.20 1.11
Cdh2
KLA  ATP  ATP+KLA
 NM_007664 cadherin 2 (Cdh2), mRNA [NM_007664] KLA 1.05 1.01 .97 .91 .98 1.10 1.01
ATP 1.01 .95 .97 .98 1.00 1.00 1.02
KLA/ATP .98 1.00 .98 1.03 .96 1.00 1.02
Cdh3
KLA  ATP  ATP+KLA
 NM_007665 cadherin 3 (Cdh3), transcript variant 2, mRNA [NM_007665] KLA 1.05 1.08 1.05 1.07 1.03 .98 1.26
ATP 1.06 .96 .97 1.04 1.03 1.05 1.06
KLA/ATP 1.00 1.00 1.07 1.01 1.02 1.09 1.18
Cdh4
KLA  ATP  ATP+KLA
 NM_009867 cadherin 4 (Cdh4), mRNA [NM_009867] KLA 1.01 .99 1.00 1.05 1.00 1.00 .94
ATP .94 1.06 1.06 .99 .99 1.01 1.02
KLA/ATP .99 1.03 1.05 .96 .98 1.00 1.01
Cdh5
KLA  ATP  ATP+KLA
 NM_009868 cadherin 5 (Cdh5), mRNA [NM_009868] KLA 1.20 1.23 1.30 1.31 1.53 1.65 1.24
ATP .99 1.00 1.08 .96 .96 1.19 1.78
KLA/ATP 1.19 1.16 1.13 1.19 1.14 1.54 2.15
Cldn1
KLA  ATP  ATP+KLA
 NM_016674 claudin 1 (Cldn1), mRNA [NM_016674] KLA .97 1.02 1.02 1.05 1.05 .99 1.07
ATP 1.02 .94 1.03 1.08 1.05 .98 1.02
KLA/ATP 1.03 1.02 1.00 1.00 1.17 1.01 1.03
Cldn10
KLA  ATP  ATP+KLA
 NM_021386 claudin 10 (Cldn10), transcript variant 2, mRNA [NM_021386] KLA 1.06 1.05 1.04 1.12 1.08 1.05 1.04
ATP 1.07 .97 .98 1.06 1.00 1.01 .97
KLA/ATP 1.01 1.06 .86 .98 1.03 1.04 1.09
Cldn11
KLA  ATP  ATP+KLA
 NM_008770 claudin 11 (Cldn11), mRNA [NM_008770] KLA 1.05 1.10 1.04 .99 .97 .99 .97
ATP 1.03 1.01 1.08 3.05 1.24 1.11 1.07
KLA/ATP 1.02 .96 1.42 2.53 1.09 1.02 1.03
Cldn13
KLA  ATP  ATP+KLA
 NM_020504 claudin 13 (Cldn13), mRNA [NM_020504] KLA 1.02 1.00 1.02 .97 1.01 .98 .99
ATP .92 .96 1.05 .96 1.02 1.04 1.04
KLA/ATP .93 .94 1.10 1.06 1.00 .93 1.03
Cldn14
KLA  ATP  ATP+KLA
 NM_019500 claudin 14 (Cldn14), mRNA [NM_019500] KLA 1.03 1.12 1.14 1.08 1.09 1.16 1.08
ATP 1.03 .99 1.12 1.04 1.07 1.10 1.06
KLA/ATP 1.07 1.14 1.21 1.12 1.07 1.10 1.08
Cldn15
KLA  ATP  ATP+KLA
 NM_021719 claudin 15 (Cldn15), mRNA [NM_021719] KLA 1.01 1.07 1.04 1.09 1.06 1.11 .98
ATP 1.17 1.26 1.27 1.08 1.24 1.11 1.05
KLA/ATP 1.25 1.31 1.19 1.22 1.70 1.26 1.03
Cldn16
KLA  ATP  ATP+KLA
 NM_053241 claudin 16 (Cldn16), mRNA [NM_053241] KLA 1.08 .98 1.02 1.00 1.06 1.05 1.00
ATP 1.01 1.05 1.01 1.12 1.05 .98 .99
KLA/ATP .98 .95 1.04 1.05 1.02 1.15 1.01
Cldn17
KLA  ATP  ATP+KLA
 NM_181490 claudin 17 (Cldn17), mRNA [NM_181490] KLA .99 1.05 1.01 1.00 .97 .99 1.01
ATP .95 .98 1.06 1.05 .97 1.00 1.00
KLA/ATP 1.04 1.00 .95 1.05 .96 1.02 1.11
Cldn18
KLA  ATP  ATP+KLA
 NM_019815 claudin 18 (Cldn18), mRNA [NM_019815] KLA .99 1.06 .99 .99 1.03 1.13 1.11
ATP .96 1.00 1.10 .98 .95 .98 1.07
KLA/ATP 1.07 .95 1.05 1.07 1.11 1.06 1.02
Cldn19
KLA  ATP  ATP+KLA
 NM_001038590 claudin 19 (Cldn19), transcript variant 1, mRNA [NM_001038590] KLA 1.06 .92 1.01 1.01 1.03 .96 1.00
ATP 1.00 .97 1.05 .93 .95 .91 1.01
KLA/ATP .93 .99 .96 .93 .91 .92 .93
Cldn19
KLA  ATP  ATP+KLA
 NM_153105 claudin 19 (Cldn19), transcript variant 2, mRNA [NM_153105] KLA .97 1.01 1.02 1.05 1.06 .96 1.09
ATP 1.04 .98 1.08 1.02 .98 1.00 .96
KLA/ATP 1.02 1.03 1.03 1.02 1.00 1.02 1.03
Cldn2
KLA  ATP  ATP+KLA
 NM_016675 claudin 2 (Cldn2), mRNA [NM_016675] KLA .98 .93 1.02 1.04 1.00 1.03 1.01
ATP 1.01 1.01 1.00 1.06 1.01 .99 1.08
KLA/ATP 1.07 1.01 .72 1.04 1.04 1.04 1.00
Cldn22
KLA  ATP  ATP+KLA
 NM_029383 claudin 22 (Cldn22), mRNA [NM_029383] KLA .99 .99 .99 .99 .99 .98 .96
ATP 1.01 .95 .99 .98 1.06 .92 .98
KLA/ATP 1.02 1.07 .96 1.00 1.02 1.04 .99
Cldn23
KLA  ATP  ATP+KLA
 NM_027998 claudin 23 (Cldn23), mRNA [NM_027998] KLA 1.33 1.38 1.29 1.23 1.13 1.13 1.20
ATP .99 1.04 1.11 1.41 1.44 1.23 1.14
KLA/ATP 1.42 1.34 1.29 1.33 1.30 1.23 1.73
Cldn3
KLA  ATP  ATP+KLA
 NM_009902 claudin 3 (Cldn3), mRNA [NM_009902] KLA 1.04 1.02 1.06 1.09 1.08 1.13 1.09
ATP 1.02 1.02 1.06 1.03 1.01 1.00 1.01
KLA/ATP 1.07 1.05 1.19 1.10 1.07 1.13 1.15
Cldn4
KLA  ATP  ATP+KLA
 NM_009903 claudin 4 (Cldn4), mRNA [NM_009903] KLA 1.05 .99 .94 1.02 1.05 1.05 .98
ATP 1.01 1.04 1.01 .95 .96 1.09 1.09
KLA/ATP .98 1.11 1.08 1.05 .86 .95 1.07
Cldn5
KLA  ATP  ATP+KLA
 NM_013805 claudin 5 (Cldn5), mRNA [NM_013805] KLA 1.08 1.08 1.23 1.13 1.16 1.18 1.18
ATP 1.01 1.02 1.03 1.03 1.05 1.00 1.06
KLA/ATP 1.14 1.18 1.13 1.09 1.05 1.15 1.16
Cldn6
KLA  ATP  ATP+KLA
 NM_018777 claudin 6 (Cldn6), mRNA [NM_018777] KLA 1.06 1.04 .98 1.01 1.03 .99 .91
ATP .98 1.01 .94 .99 .95 1.14 1.07
KLA/ATP 1.02 .96 1.08 1.04 1.01 .95 1.05
Cldn7
KLA  ATP  ATP+KLA
 NM_016887 claudin 7 (Cldn7), mRNA [NM_016887] KLA 1.21 1.23 1.33 1.38 1.44 1.26 1.01
ATP 1.01 1.01 1.07 1.01 1.04 1.04 1.03
KLA/ATP 1.22 1.28 1.24 2.23 1.42 1.17 1.07
Cldn8
KLA  ATP  ATP+KLA
 NM_018778 claudin 8 (Cldn8), mRNA [NM_018778] KLA .98 .86 1.00 .98 1.02 1.06 .97
ATP .93 .99 1.01 1.00 1.05 1.01 1.03
KLA/ATP .98 1.08 .96 1.00 1.02 .98 1.00
Cldn9
KLA  ATP  ATP+KLA
 NM_020293 claudin 9 (Cldn9), mRNA [NM_020293] KLA 1.29 1.24 1.37 1.34 1.32 1.37 1.55
ATP .92 .90 1.30 1.47 1.43 1.32 1.12
KLA/ATP 1.16 1.26 2.03 1.63 1.89 1.39 1.30
Cntn1
KLA  ATP  ATP+KLA
 AK140433 10 days neonate medulla oblongata cDNA, RIKEN full-length enriched library, clone:B830008A22 product:contactin 1, full insert sequence [AK140433] KLA .96 1.00 .99 .98 .90 .97 .95
ATP 1.04 .98 1.03 1.02 1.09 .93 1.01
KLA/ATP .99 .93 .93 .97 .98 .97 .92
Cntn1
KLA  ATP  ATP+KLA
 AY512913 clone NIA:K0221A09 unknown mRNA [AY512913] KLA .95 1.04 1.03 .95 1.04 1.01 .96
ATP .99 1.03 .89 .94 .87 .95 1.04
KLA/ATP .98 1.05 1.00 .94 .97 .90 1.01
Cntn1
KLA  ATP  ATP+KLA
 NM_007727 contactin 1 (Cntn1), mRNA [NM_007727] KLA 1.04 .98 .96 .98 .96 .97 1.00
ATP .99 1.03 1.06 .97 1.03 .97 1.01
KLA/ATP 1.09 .97 1.11 .99 .97 1.01 1.03
Cntn2
KLA  ATP  ATP+KLA
 NM_177129 contactin 2 (Cntn2), mRNA [NM_177129] KLA .97 .98 1.03 .98 1.03 1.00 .97
ATP 1.08 .96 1.00 1.00 .98 .99 .97
KLA/ATP 1.01 1.03 1.01 .99 .94 1.01 .95
Cntnap1
KLA  ATP  ATP+KLA
 AF039833 neurexin IV mRNA, complete cds. [AF039833] KLA 1.04 .97 1.04 1.07 1.04 .96 1.10
ATP .98 1.01 .99 .96 1.09 1.04 .95
KLA/ATP .99 1.03 .95 1.01 .92 .98 .95
Cntnap1
KLA  ATP  ATP+KLA
 NM_016782 contactin associated protein-like 1 (Cntnap1), mRNA [NM_016782] KLA 1.17 1.08 1.16 1.12 1.13 1.16 1.13
ATP .97 .97 1.06 1.14 1.12 1.12 1.11
KLA/ATP 1.15 1.24 1.24 1.22 1.23 1.23 1.16
Cntnap2
KLA  ATP  ATP+KLA
 NM_001004357 contactin associated protein-like 2 (Cntnap2), transcript variant 1, mRNA [NM_001004357] KLA 1.01 .98 .98 1.07 .98 .97 .94
ATP .90 .98 1.02 .99 .92 1.01 .99
KLA/ATP 1.00 1.08 1.03 .98 1.04 1.00 .97
Cntnap2
KLA  ATP  ATP+KLA
 NM_025771 contactin associated protein-like 2 (Cntnap2), transcript variant 2, mRNA [NM_025771] KLA 1.02 .99 1.02 1.00 1.03 1.05 1.03
ATP 1.06 1.05 1.05 1.03 1.05 1.07 1.02
KLA/ATP 1.01 .97 .96 1.06 1.12 1.05 1.00
Ctla4
KLA  ATP  ATP+KLA
 NM_009843 cytotoxic T-lymphocyte-associated protein 4 (Ctla4), mRNA [NM_009843] KLA 1.00 1.04 1.01 1.01 .97 1.01 1.09
ATP 1.01 .98 1.06 .96 .96 .98 1.03
KLA/ATP 1.05 1.06 1.02 .90 .99 .99 1.02
Esam1
KLA  ATP  ATP+KLA
 NM_027102 endothelial cell-specific adhesion molecule (Esam1), mRNA [NM_027102] KLA 1.00 1.03 1.04 1.05 1.02 1.11 1.12
ATP 1.03 1.00 1.02 1.13 1.21 1.36 1.14
KLA/ATP 1.05 1.00 1.04 1.16 1.30 1.53 1.29
F11r
KLA  ATP  ATP+KLA
 NM_172647 F11 receptor (F11r), mRNA [NM_172647] KLA 7.81 8.47 6.77 8.24 6.97 3.97 1.27
ATP .91 .90 1.38 1.45 3.39 8.01 2.55
KLA/ATP 6.57 8.31 8.96 8.00 8.69 7.39 14.52
Glg1
KLA  ATP  ATP+KLA
 AK050772 9 days embryo whole body cDNA, RIKEN full-length enriched library, clone:D030018I01 product:selectin, endothelial cell, ligand, full insert sequence. [AK050772] KLA .66 .59 .63 .50 .62 .55 .65
ATP 1.28 1.18 .87 .90 .73 .40 .54
KLA/ATP .77 .73 .49 .49 .42 .43 .58
Glg1
KLA  ATP  ATP+KLA
 NM_009149 golgi apparatus protein 1 (Glg1), mRNA [NM_009149] KLA .57 .52 .48 .46 .46 .50 .60
ATP .89 .82 1.03 .56 .58 .43 .69
KLA/ATP .55 .49 .52 .29 .34 .34 .66
Glycam1
KLA  ATP  ATP+KLA
 NM_008134 glycosylation dependent cell adhesion molecule 1 (Glycam1), mRNA [NM_008134] KLA .98 1.03 1.10 1.01 1.04 1.00 1.02
ATP .98 1.07 .99 .99 .93 1.07 1.09
KLA/ATP 1.03 .97 1.07 1.00 .95 .98 .99
H2-Aa
KLA  ATP  ATP+KLA
 NM_010378 histocompatibility 2, class II antigen A, alpha (H2-Aa), mRNA [NM_010378] KLA 1.43 1.59 1.68 1.50 1.62 1.89 1.64
ATP 1.07 1.15 1.27 1.90 1.92 1.77 1.55
KLA/ATP 1.62 1.81 1.74 2.29 1.89 1.92 2.19
H2-Ab1
KLA  ATP  ATP+KLA
 BC010322 histocompatibility 2, class II antigen A, beta 1, mRNA (cDNA clone MGC:6297 IMAGE:2651058), complete cds [BC010322] KLA 1.73 1.76 1.77 1.55 1.95 2.10 2.27
ATP 1.03 1.18 1.32 1.99 1.79 1.56 1.61
KLA/ATP 1.70 2.01 1.74 2.52 1.58 2.01 2.75
H2-Ab1
KLA  ATP  ATP+KLA
 NM_207105 histocompatibility 2, class II antigen A, beta 1 (H2-Ab1), mRNA [NM_207105] KLA 2.02 2.15 2.07 2.09 2.32 2.78 3.08
ATP 1.11 1.20 1.42 2.33 2.33 2.25 1.87
KLA/ATP 2.11 2.32 2.52 3.62 2.67 2.96 5.04
H2-Bl
KLA  ATP  ATP+KLA
 NM_008199 histocompatibility 2, blastocyst (H2-Bl), mRNA [NM_008199] KLA 1.29 1.32 1.40 1.28 1.36 1.46 1.80
ATP 1.04 1.11 1.02 1.34 1.28 1.32 1.47
KLA/ATP 1.32 1.39 1.34 1.77 1.41 1.61 2.39
H2-D1
KLA  ATP  ATP+KLA
 AK169750 2 days neonate thymus thymic cells cDNA, RIKEN full-length enriched library, clone:E430019E13 product:histocompatibility 2, D region locus 1, full insert sequence [AK169750] KLA .99 .98 .96 .99 .93 .91 .94
ATP .96 1.01 1.02 .95 1.05 1.00 .98
KLA/ATP .92 .94 .97 .97 .98 .92 1.03
H2-D1
KLA  ATP  ATP+KLA
 NM_010380 histocompatibility 2, D region locus 1 (H2-D1), mRNA [NM_010380] KLA 1.38 1.45 1.73 1.42 1.70 1.76 2.56
ATP 1.15 1.11 .86 1.12 1.19 1.28 1.90
KLA/ATP 1.58 1.72 1.38 1.56 1.38 1.69 3.21
H2-DMa
KLA  ATP  ATP+KLA
 NM_010386 histocompatibility 2, class II, locus DMa (H2-DMa), mRNA [NM_010386] KLA 1.49 1.50 1.65 1.65 1.91 2.23 1.69
ATP 1.04 1.12 1.26 1.67 1.24 .99 1.32
KLA/ATP 1.58 1.68 1.70 2.02 1.37 1.35 1.90
H2-DMb1
KLA  ATP  ATP+KLA
 NM_010387 histocompatibility 2, class II, locus Mb1 (H2-DMb1), mRNA [NM_010387] KLA 1.06 1.14 1.08 1.13 1.24 1.41 1.37
ATP 1.01 1.02 1.09 1.14 .92 .73 1.36
KLA/ATP 1.13 1.05 1.21 1.17 .98 .83 1.41
H2-DMb2
KLA  ATP  ATP+KLA
 NM_010388 histocompatibility 2, class II, locus Mb2 (H2-DMb2), mRNA [NM_010388] KLA 1.00 1.04 .93 .95 .96 .95 1.03
ATP 1.06 1.04 .94 .92 .97 .95 1.00
KLA/ATP .90 .94 .99 .94 .90 .96 .92
H2-Eb1
KLA  ATP  ATP+KLA
 X52641 gb|Mouse mRNA for I-A beta NOD. [X52641] KLA 1.94 2.06 1.94 1.87 1.96 2.18 1.76
ATP 1.11 1.20 1.53 2.70 3.02 2.91 1.40
KLA/ATP 2.09 2.11 2.26 3.55 2.76 3.05 3.05
H2-K1
KLA  ATP  ATP+KLA
 M69070 mRNA, complete cds. [M69070] KLA 1.76 1.66 1.78 1.78 1.87 2.23 2.99
ATP .98 .97 1.19 1.45 1.36 1.68 2.17
KLA/ATP 1.68 1.70 1.87 1.96 1.87 2.13 3.82
H2-K1
KLA  ATP  ATP+KLA
 NM_001001892 histocompatibility 2, K1, K region (H2-K1), transcript variant 1, mRNA [NM_001001892] KLA 1.82 1.66 1.73 1.76 1.87 2.29 3.17
ATP .98 .97 1.13 1.32 1.29 1.57 2.09
KLA/ATP 1.64 1.71 1.77 1.82 1.71 2.12 3.91
H2-M1
KLA  ATP  ATP+KLA
 NM_177636 histocompatibility 2, M region locus 1 (H2-M1), mRNA [NM_177636] KLA .99 1.01 1.02 1.02 .97 1.03 1.04
ATP 1.01 .99 1.03 1.07 .92 1.03 .98
KLA/ATP 1.08 .97 .94 1.04 1.00 1.04 1.02
H2-M10.1
KLA  ATP  ATP+KLA
 NM_013544 histocompatibility 2, M region locus 10.1 (H2-M10.1), mRNA [NM_013544] KLA 1.04 1.00 1.05 .95 .98 1.04 .94
ATP 1.06 1.04 .96 .95 .97 .98 .98
KLA/ATP 1.02 1.07 .98 1.02 .92 .92 .99
H2-M10.2
KLA  ATP  ATP+KLA
 NM_177923 histocompatibility 2, M region locus 10.2 (H2-M10.2), mRNA [NM_177923] KLA 2.18 2.23 2.51 2.61 2.90 3.30 3.40
ATP 1.08 1.02 1.22 1.39 1.30 1.56 2.66
KLA/ATP 2.23 2.53 2.82 2.91 2.89 2.60 3.92
H2-M10.3
KLA  ATP  ATP+KLA
 AY211080 major histocompatibility complex class Ib M10.3 mRNA, complete cds [AY211080] KLA .95 1.08 .99 .95 1.00 1.11 1.04
ATP .98 .96 1.00 .99 1.00 .99 1.00
KLA/ATP 1.00 .99 1.00 1.00 .99 .96 1.03
H2-M10.4
KLA  ATP  ATP+KLA
 NM_177634 histocompatibility 2, M region locus 10.4 (H2-M10.4), mRNA [NM_177634] KLA 1.03 1.04 1.08 1.08 1.04 1.03 1.03
ATP 1.07 1.05 .97 1.08 .95 .97 1.02
KLA/ATP 1.02 .97 1.02 .99 .93 1.06 1.04
H2-M10.5
KLA  ATP  ATP+KLA
 NM_177637 histocompatibility 2, M region locus 10.5 (H2-M10.5), mRNA [NM_177637] KLA 1.00 1.04 1.13 .93 .99 1.00 1.07
ATP 1.02 1.02 1.04 .90 1.03 .99 .99
KLA/ATP 1.06 1.03 .97 1.03 1.03 .98 1.04
H2-M10.6
KLA  ATP  ATP+KLA
 NM_201611 histocompatibility 2, M region locus 10.6 (H2-M10.6), mRNA [NM_201611] KLA 1.06 .99 1.04 1.06 .98 1.03 .92
ATP 1.04 1.09 .96 .98 .94 1.07 .98
KLA/ATP 1.01 1.06 1.02 .96 .96 1.04 1.05
H2-M11
KLA  ATP  ATP+KLA
 NM_177635 histocompatibility 2, M region locus 11 (H2-M11), mRNA [NM_177635] KLA 1.03 1.07 1.06 1.02 .96 1.05 1.03
ATP 1.02 .96 1.08 .98 1.04 .94 .98
KLA/ATP 1.03 1.03 .99 1.01 1.01 .98 .99
H2-M3
KLA  ATP  ATP+KLA
 NM_013819 histocompatibility 2, M region locus 3 (H2-M3), mRNA [NM_013819] KLA 1.90 2.04 2.09 2.37 2.30 2.56 2.73
ATP 1.00 1.00 1.19 1.34 1.00 .70 1.09
KLA/ATP 1.77 1.94 2.37 2.49 1.89 1.67 2.06
H2-M9
KLA  ATP  ATP+KLA
 NM_008205 histocompatibility 2, M region locus 9 (H2-M9), mRNA [NM_008205] KLA 1.03 .99 .96 .98 1.01 .99 1.03
ATP .96 1.06 .94 .96 1.05 1.06 1.00
KLA/ATP .96 1.01 1.01 .99 .97 .95 .98
H2-Oa
KLA  ATP  ATP+KLA
 NM_008206 histocompatibility 2, O region alpha locus (H2-Oa), mRNA [NM_008206] KLA 1.22 1.32 1.37 1.33 1.31 1.26 1.53
ATP 1.02 1.05 1.16 1.21 1.12 1.07 1.16
KLA/ATP 1.32 1.34 1.31 1.34 1.25 1.35 2.78
H2-Ob
KLA  ATP  ATP+KLA
 NM_010389 histocompatibility 2, O region beta locus (H2-Ob), mRNA [NM_010389] KLA 1.05 1.07 1.01 .96 1.10 1.02 1.00
ATP 1.04 .99 1.00 1.03 .94 1.07 .94
KLA/ATP 1.02 .97 1.06 1.08 1.00 .96 1.05
H2-Q1
KLA  ATP  ATP+KLA
 NM_010390 histocompatibility 2, Q region locus 1 (H2-Q1), mRNA [NM_010390] KLA 1.05 1.08 1.03 1.02 .98 1.09 1.00
ATP .99 .92 .93 1.01 1.01 1.04 1.00
KLA/ATP 1.07 1.00 1.00 .91 .97 1.07 1.04
H2-Q10
KLA  ATP  ATP+KLA
 NM_010391 histocompatibility 2, Q region locus 10 (H2-Q10), mRNA [NM_010391] KLA 1.50 1.50 1.70 1.64 1.67 1.79 2.18
ATP 1.12 1.11 1.09 1.46 1.42 1.43 1.69
KLA/ATP 1.61 1.72 1.79 1.94 1.81 1.81 2.93
H2-Q2
KLA  ATP  ATP+KLA
 NM_010392 histocompatibility 2, Q region locus 2 (H2-Q2), mRNA [NM_010392] KLA 1.55 1.52 1.61 1.45 1.83 1.94 2.47
ATP 1.09 1.13 .92 1.16 1.17 1.30 1.88
KLA/ATP 1.55 1.70 1.58 1.80 1.64 1.87 3.43
H2-Q7
KLA  ATP  ATP+KLA
 NM_010394 histocompatibility 2, Q region locus 7 (H2-Q7), mRNA [NM_010394] KLA 1.57 1.58 1.74 1.55 1.82 2.00 2.76
ATP 1.05 1.09 .84 1.12 1.12 1.23 2.00
KLA/ATP 1.63 1.75 1.43 1.67 1.53 1.80 3.48
H2-Q8
KLA  ATP  ATP+KLA
 NM_023124 histocompatibility 2, Q region locus 8 (H2-Q8), mRNA [NM_023124] KLA 7.48 6.46 6.41 7.15 7.46 9.60 18.27
ATP 1.01 .98 1.48 2.05 1.93 3.83 8.26
KLA/ATP 6.72 7.10 9.11 10.95 10.71 12.88 31.43
H2-T22
KLA  ATP  ATP+KLA
 NM_010397 histocompatibility 2, T region locus 22 (H2-T22), mRNA [NM_010397] KLA 5.21 5.40 5.81 6.31 7.42 9.49 7.50
ATP 1.01 .95 .88 .92 .93 3.65 5.53
KLA/ATP 4.83 5.12 4.58 4.74 4.81 6.89 14.89
H2-T23
KLA  ATP  ATP+KLA
 NM_010398 histocompatibility 2, T region locus 23 (H2-T23), mRNA [NM_010398] KLA 1.83 1.80 1.92 1.86 2.32 2.56 3.43
ATP 1.03 1.08 .85 1.18 1.09 1.30 2.49
KLA/ATP 1.76 1.92 1.62 1.93 1.76 2.13 4.06
H2-T24
KLA  ATP  ATP+KLA
 NM_008207 histocompatibility 2, T region locus 24 (H2-T24), mRNA [NM_008207] KLA 3.02 3.26 4.14 4.26 5.15 6.06 5.89
ATP 1.08 1.09 1.32 1.35 1.17 1.71 6.71
KLA/ATP 3.23 3.31 3.54 3.85 3.07 3.73 9.10
H2-T3
KLA  ATP  ATP+KLA
 NM_008208 histocompatibility 2, T region locus 3 (H2-T3), mRNA [NM_008208] KLA .95 1.04 1.00 .97 .97 .99 1.00
ATP .98 1.08 1.03 1.01 .98 1.02 1.03
KLA/ATP 1.05 .96 1.02 1.04 1.05 1.00 .97
Icam1
KLA  ATP  ATP+KLA
 BC008626 intercellular adhesion molecule, mRNA (cDNA clone MGC:6195 IMAGE:3588949), complete cds [BC008626] KLA 36.67 32.93 28.63 27.91 14.65 8.16 4.15
ATP .96 .88 1.50 3.88 4.98 3.90 1.01
KLA/ATP 32.58 31.60 42.74 32.60 26.00 13.02 6.01
Icam1
KLA  ATP  ATP+KLA
 NM_010493 intercellular adhesion molecule 1 (Icam1), mRNA [NM_010493] KLA 15.66 15.20 12.96 12.31 9.39 6.17 3.81
ATP .96 1.06 1.21 4.19 4.33 3.16 1.06
KLA/ATP 14.31 15.46 17.84 17.60 13.77 8.36 5.42
Icam2
KLA  ATP  ATP+KLA
 NM_010494 intercellular adhesion molecule 2 (Icam2), mRNA [NM_010494] KLA .90 .84 .82 .72 .67 .61 .70
ATP 1.08 .96 1.28 1.48 2.29 1.22 .62
KLA/ATP .89 .89 1.11 1.00 1.32 1.23 .87
Icos
KLA  ATP  ATP+KLA
 AK030827 adult male thymus cDNA, RIKEN full-length enriched library, clone:5830414M16 product:inducible T-cell co-stimulator, full insert sequence [AK030827] KLA .99 .91 .97 .99 .94 .90 .78
ATP 1.06 .97 1.03 .88 .90 .91 .79
KLA/ATP .92 .99 .98 .97 .95 .90 .80
Icos
KLA  ATP  ATP+KLA
 NM_017480 inducible T-cell co-stimulator (Icos), mRNA [NM_017480] KLA 1.01 .96 .86 .95 .92 .91 .84
ATP .99 1.05 1.00 .98 .96 .97 .86
KLA/ATP .95 .98 .94 1.00 .96 .88 .87
Icosl
KLA  ATP  ATP+KLA
 NM_015790 icos ligand (Icosl), mRNA [NM_015790] KLA 3.89 3.36 2.85 2.20 1.82 1.29 .91
ATP 1.07 1.04 1.27 1.54 1.36 1.34 .57
KLA/ATP 3.24 3.83 4.40 3.17 1.62 1.53 .96
Itga4
KLA  ATP  ATP+KLA
 NM_010576 integrin alpha 4 (Itga4), mRNA [NM_010576] KLA 4.65 4.83 4.47 3.76 2.93 1.65 1.01
ATP 1.10 1.12 1.17 1.08 .86 .75 .36
KLA/ATP 4.82 5.02 4.43 3.69 2.11 1.13 .79
Itga6
KLA  ATP  ATP+KLA
 BC024571 integrin alpha 6, mRNA (cDNA clone IMAGE:5036677). [BC024571] KLA .44 .44 .37 .28 .25 .29 .34
ATP .96 1.01 .90 .58 .35 .11 .22
KLA/ATP .44 .41 .34 .23 .15 .09 .08
Itga6
KLA  ATP  ATP+KLA
 NM_008397 integrin alpha 6 (Itga6), mRNA [NM_008397] KLA .57 .58 .51 .45 .43 .44 .47
ATP 1.05 1.12 .86 .90 .57 .27 .36
KLA/ATP .64 .67 .50 .57 .39 .29 .26
Itga8
KLA  ATP  ATP+KLA
 NM_001001309 integrin alpha 8 (Itga8), mRNA [NM_001001309] KLA .80 .81 .79 .75 .63 .61 .44
ATP .98 1.04 1.06 .94 .79 .61 .50
KLA/ATP .79 .81 .81 .71 .70 .65 .48
Itgal
KLA  ATP  ATP+KLA
 AK156251 activated spleen cDNA, RIKEN full-length enriched library, clone:F830013L17 product:integrin alpha L, full insert sequence [AK156251] KLA 5.36 5.78 4.86 5.55 7.02 8.63 11.12
ATP .99 1.17 1.22 1.57 1.35 1.95 3.79
KLA/ATP 5.42 5.89 4.95 5.91 3.96 4.93 10.15
Itgal
KLA  ATP  ATP+KLA
 NM_008400 integrin alpha L (Itgal), mRNA [NM_008400] KLA 4.48 5.17 5.28 5.82 7.82 8.09 16.96
ATP 1.03 1.06 1.24 1.44 1.34 2.02 4.59
KLA/ATP 4.71 5.63 5.49 5.60 3.66 4.65 17.76
Itgam
KLA  ATP  ATP+KLA
 NM_001082960 integrin alpha M (Itgam), transcript variant 1, mRNA [NM_001082960] KLA 1.04 1.12 1.14 1.07 1.54 1.80 1.72
ATP 1.17 1.19 .97 1.16 .86 .65 1.33
KLA/ATP 1.19 1.19 .94 1.06 .64 .59 1.08
Itgam
KLA  ATP  ATP+KLA
 NM_008401 integrin alpha M (Itgam), transcript variant 2, mRNA [NM_008401] KLA 1.20 1.16 1.21 1.34 1.59 1.79 1.64
ATP 1.15 1.16 .94 1.20 1.00 .78 1.25
KLA/ATP 1.32 1.37 1.29 1.14 .84 .75 1.16
Itgav
KLA  ATP  ATP+KLA
 AK052514 13 days embryo lung cDNA, RIKEN full-length enriched library, clone:D430040G12 product:hypothetical protein, full insert sequence. [AK052514] KLA 1.04 .93 1.05 1.02 1.01 .93 1.03
ATP 1.05 1.04 1.13 1.12 1.12 .91 1.02
KLA/ATP 1.08 .97 1.02 .95 1.01 .96 1.05
Itgav
KLA  ATP  ATP+KLA
 AK171739 activated spleen cDNA, RIKEN full-length enriched library, clone:F830008B15 product:unclassifiable, full insert sequence. [AK171739] KLA 1.04 .97 1.06 .95 1.15 .89 1.11
ATP 1.41 1.54 1.64 2.24 2.74 1.24 1.18
KLA/ATP 1.09 1.07 1.03 1.01 1.72 1.24 1.10
Itgav
KLA  ATP  ATP+KLA
 NM_008402 integrin alpha V (Itgav), mRNA [NM_008402] KLA 4.00 3.99 3.28 2.24 1.57 .95 1.13
ATP 1.14 1.22 1.13 1.39 2.22 2.47 1.70
KLA/ATP 4.59 4.61 2.48 2.44 1.60 1.88 2.56
Itgb1
KLA  ATP  ATP+KLA
 NM_010578 integrin beta 1 (fibronectin receptor beta) (Itgb1), mRNA [NM_010578] KLA 1.05 1.09 1.13 .92 1.01 .93 .88
ATP 1.14 1.30 .92 1.07 1.04 .83 .70
KLA/ATP 1.26 1.30 .87 1.02 .66 .65 .62
Itgb1
KLA  ATP  ATP+KLA
 U37029 integrin beta1D mRNA, partial cds. [U37029] KLA .93 .95 .96 1.01 .97 1.01 .98
ATP 1.05 .99 .99 1.03 1.03 .97 .94
KLA/ATP .99 .98 1.04 .97 1.02 1.01 .99
Itgb2
KLA  ATP  ATP+KLA
 NM_008404 integrin beta 2 (Itgb2), mRNA [NM_008404] KLA .78 .78 .97 .74 1.04 .94 1.14
ATP 1.24 1.23 .79 .95 1.12 .84 1.10
KLA/ATP .99 1.01 .60 .83 .78 .73 .99
Itgb2l
KLA  ATP  ATP+KLA
 NM_008405 integrin beta 2-like (Itgb2l), mRNA [NM_008405] KLA .87 .98 .98 1.00 1.05 1.07 1.10
ATP 1.24 1.23 1.13 1.14 1.29 1.05 1.05
KLA/ATP 1.02 1.08 1.08 1.06 .98 .93 .95
Itgb7
KLA  ATP  ATP+KLA
 NM_013566 integrin beta 7 (Itgb7), mRNA [NM_013566] KLA .91 .88 .93 1.19 .93 .76 .79
ATP 1.00 .96 1.30 1.44 2.84 3.07 7.90
KLA/ATP .96 1.05 1.35 1.20 2.70 3.53 8.17
Itgb8
KLA  ATP  ATP+KLA
 AK029281 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4832412O06 product:SIMILAR TO INTEGRIN, BETA 8 homolog [Homo sapiens], full insert sequence. [AK029281] KLA 4.66 5.00 3.59 2.70 1.76 1.34 1.32
ATP 1.01 .98 1.09 1.16 2.15 5.24 1.17
KLA/ATP 5.59 6.39 4.38 1.99 1.84 2.55 2.11
Itgb8
KLA  ATP  ATP+KLA
 AK034644 12 days embryo embryonic body between diaphragm region and neck cDNA, RIKEN full-length enriched library, clone:9430018C17 product:integrin beta 8, full insert sequence. [AK034644] KLA 1.18 1.02 1.04 1.03 1.05 .94 .93
ATP .96 .97 .97 .96 .90 1.04 .99
KLA/ATP 1.06 1.06 1.15 .92 .99 1.00 1.09
Itgb8
KLA  ATP  ATP+KLA
 AK140969 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130086L01 product:hypothetical protein, full insert sequence [AK140969] KLA 3.63 3.76 4.16 3.31 2.72 1.58 1.40
ATP .98 1.01 1.31 1.14 1.28 6.11 1.65
KLA/ATP 3.84 4.18 3.75 2.83 1.92 3.44 4.81
Jam2
KLA  ATP  ATP+KLA
 NM_023844 junction adhesion molecule 2 (Jam2), mRNA [NM_023844] KLA 1.84 2.17 1.88 1.76 1.69 1.51 1.46
ATP .97 .93 1.16 1.13 1.15 1.55 1.21
KLA/ATP 1.77 2.07 1.89 1.54 1.41 1.56 1.52
Jam3
KLA  ATP  ATP+KLA
 AK017692 8 days embryo whole body cDNA, RIKEN full-length enriched library, clone:5730470H08 product:junction cell adhesion molecule 3, full insert sequence. [AK017692] KLA .94 1.00 1.01 1.00 1.02 1.00 .93
ATP .97 .99 1.03 .97 .98 .96 .94
KLA/ATP .94 1.04 .94 .91 .93 .87 1.03
Jam3
KLA  ATP  ATP+KLA
 NM_023277 junction adhesion molecule 3 (Jam3), mRNA [NM_023277] KLA .97 1.02 1.06 1.06 1.01 .98 .74
ATP 1.07 1.00 .98 .96 .89 .88 .67
KLA/ATP 1.13 1.07 1.07 .97 .94 .91 .68
L1cam
KLA  ATP  ATP+KLA
 NM_008478 L1 cell adhesion molecule (L1cam), mRNA [NM_008478] KLA .96 .96 1.06 .81 .79 .64 .49
ATP 1.15 1.42 .96 1.43 .92 .62 .64
KLA/ATP 1.16 1.14 .74 .99 .66 .58 .54
LOC10004
3181
KLA  ATP  ATP+KLA
 XM_001479688 gb|PREDICTED: Mus musculus hypothetical protein LOC100043181 (LOC100043181), mRNA [XM_001479688] KLA 1.01 1.02 1.01 1.02 1.03 1.01 1.01
ATP 1.00 1.04 1.00 1.02 1.00 1.03 1.00
KLA/ATP 1.01 1.00 1.04 1.02 1.02 .98 1.02
LOC67670
8
KLA  ATP  ATP+KLA
 XM_992322 ref|PREDICTED: Mus musculus similar to class I (Qa) Q2k antigen (LOC676708), mRNA [XM_992322] KLA 2.18 2.22 2.32 2.27 2.28 2.77 3.62
ATP 1.04 1.17 1.17 2.19 1.83 1.75 2.30
KLA/ATP 2.20 2.44 2.25 3.41 2.30 2.63 5.00
Lrrc4
KLA  ATP  ATP+KLA
 NM_138682 leucine rich repeat containing 4 (Lrrc4), mRNA [NM_138682] KLA 2.49 1.96 2.25 3.78 4.57 8.02 5.57
ATP .88 .73 .97 .65 .38 .57 2.88
KLA/ATP 1.91 1.76 1.97 1.38 1.31 2.33 6.93
Lrrc4b
KLA  ATP  ATP+KLA
 NM_198250 leucine rich repeat containing 4B (Lrrc4b), mRNA [NM_198250] KLA .99 .92 .99 1.05 1.00 1.02 1.03
ATP 1.03 1.01 .98 .98 .99 .98 .87
KLA/ATP 1.02 1.07 .97 .96 .89 .95 1.01
Lrrc4c
KLA  ATP  ATP+KLA
 NM_178725 leucine rich repeat containing 4C (Lrrc4c), mRNA [NM_178725] KLA 1.03 .99 1.03 .99 .97 .96 1.01
ATP .98 1.03 .95 1.00 .99 .97 1.00
KLA/ATP .97 1.10 1.00 1.04 1.01 .99 .98
Madcam1
KLA  ATP  ATP+KLA
 NM_013591 mucosal vascular addressin cell adhesion molecule 1 (Madcam1), mRNA [NM_013591] KLA .98 1.03 1.03 1.00 .99 .98 1.04
ATP .87 1.01 1.01 1.02 .95 1.04 .94
KLA/ATP 1.04 1.16 1.03 1.01 .97 .92 .95
Mag
KLA  ATP  ATP+KLA
 NM_010758 myelin-associated glycoprotein (Mag), mRNA [NM_010758] KLA 1.29 1.27 1.46 1.56 1.96 2.34 2.35
ATP 1.05 1.15 1.17 1.27 1.15 .97 1.37
KLA/ATP 1.37 1.40 1.37 1.47 1.37 1.30 1.54
Mm.10799
6
KLA  ATP  ATP+KLA
 94407580 Unknown KLA .97 .95 .93 1.00 .95 1.00 1.00
ATP .95 1.03 .96 .92 1.03 .93 1.05
KLA/ATP .99 .91 .97 .92 .90 .90 .92
Mm.15909
3
KLA  ATP  ATP+KLA
 149272242 Unknown KLA 1.01 .97 1.01 1.01 1.05 1.02 .99
ATP 1.04 1.01 .95 1.02 .99 .94 .96
KLA/ATP .96 1.01 1.04 .94 .94 1.05 .98
Mm.19506
1
KLA  ATP  ATP+KLA
 76253707 Unknown KLA 5.35 4.83 5.36 6.20 6.87 9.80 7.83
ATP .97 .90 .96 .77 .80 3.98 5.87
KLA/ATP 4.63 4.51 4.51 3.75 4.39 7.21 16.38
Mm.25500
3
KLA  ATP  ATP+KLA
 161484596 Unknown KLA .35 .34 .35 .34 .22 .19 .10
ATP 1.09 1.27 1.13 1.29 2.25 1.66 2.22
KLA/ATP .38 .36 .39 .40 .49 .42 .32
Mm.25743
7
KLA  ATP  ATP+KLA
 161760626 Unknown KLA 1.00 1.03 1.07 1.00 .95 1.08 1.06
ATP 1.00 1.14 1.03 .99 1.05 1.03 1.02
KLA/ATP 1.03 1.04 1.00 1.01 1.04 1.00 1.01
Mm.26086
1
KLA  ATP  ATP+KLA
 124248523 Unknown KLA 1.05 .98 1.03 1.04 .96 1.02 1.08
ATP 1.01 1.00 1.05 .99 .91 .98 1.02
KLA/ATP 1.04 1.07 .97 1.09 1.07 1.09 1.04
Mm.29798
KLA  ATP  ATP+KLA
 161484605 Unknown KLA .94 .94 .80 .86 .71 .87 .67
ATP 1.01 1.01 1.53 1.48 1.31 1.06 .75
KLA/ATP .93 .95 .95 .89 .87 .92 .78
Mm.31180
9
KLA  ATP  ATP+KLA
 6679562 Unknown KLA 1.00 1.03 1.18 1.08 1.06 1.28 6.03
ATP 1.03 1.00 1.03 1.08 .87 .99 1.15
KLA/ATP 1.07 1.12 1.00 1.12 1.03 1.06 1.17
Mm.33314
8
KLA  ATP  ATP+KLA
 118129874 Unknown KLA 1.04 1.03 1.05 1.08 1.05 1.02 1.00
ATP .95 1.08 .99 .91 .96 1.03 1.07
KLA/ATP .99 1.00 1.02 .98 1.00 .98 1.10
Mm.33509
6
KLA  ATP  ATP+KLA
 40254533 Unknown KLA .68 .70 .59 .64 .45 .52 .51
ATP .99 1.04 1.00 .80 1.26 1.55 .86
KLA/ATP .68 .74 .66 .70 1.21 1.77 .77
Mm.41078
3
KLA  ATP  ATP+KLA
 124486954 Unknown KLA 23.17 21.90 23.20 26.54 21.31 19.97 2.79
ATP .96 .92 1.54 1.73 3.61 19.17 7.67
KLA/ATP 21.17 22.95 31.95 22.98 19.64 18.78 14.63
Mm.41758
KLA  ATP  ATP+KLA
 148747503 Unknown KLA 1.68 1.98 1.80 1.70 1.53 1.43 1.42
ATP 1.05 1.08 1.12 1.06 1.09 1.51 1.15
KLA/ATP 1.74 2.06 1.81 1.45 1.47 1.42 1.55
Mm.42304
0
KLA  ATP  ATP+KLA
 94418669 Unknown KLA 1.04 1.14 1.04 1.04 .98 1.05 1.08
ATP .97 .99 1.27 1.21 1.09 1.01 1.03
KLA/ATP 1.07 1.09 1.08 1.06 1.03 1.02 .95
Mm.4341
KLA  ATP  ATP+KLA
 31982076 Unknown KLA 15.21 12.82 10.30 10.79 6.76 4.53 2.96
ATP 1.06 .90 .81 .46 .58 1.71 .85
KLA/ATP 11.00 11.87 16.67 9.82 6.57 3.88 2.71
Mm.43967
5
KLA  ATP  ATP+KLA
 133778954 Unknown KLA 1.76 1.74 1.70 1.72 1.75 2.14 3.19
ATP 1.00 1.01 1.18 1.28 1.25 1.48 1.84
KLA/ATP 1.67 1.64 1.70 1.79 1.63 2.04 3.36
Mm.43967
5
KLA  ATP  ATP+KLA
 149275074 Unknown KLA 2.17 2.23 2.26 2.58 2.26 2.10 1.43
ATP .96 .91 1.12 .90 .70 1.10 1.47
KLA/ATP 1.96 2.10 1.92 1.51 1.12 1.35 1.99
Mm.44165
1
KLA  ATP  ATP+KLA
 160333403 Unknown KLA 5.45 5.27 5.02 6.34 6.63 10.05 8.10
ATP .91 .84 .96 .75 .78 3.91 6.03
KLA/ATP 4.29 4.38 4.50 3.55 4.22 7.22 17.63
Mm.46438
KLA  ATP  ATP+KLA
 140970932 Unknown KLA .96 1.02 1.00 .99 .92 .94 .84
ATP .95 1.02 1.00 .97 1.04 1.20 .90
KLA/ATP 1.02 .95 .91 .92 1.00 1.18 .88
Mm.5245
KLA  ATP  ATP+KLA
 118130193 Unknown KLA 1.62 1.58 1.58 1.32 1.15 1.18 1.17
ATP .95 .99 1.18 1.78 1.34 1.15 1.03
KLA/ATP 1.66 1.70 1.66 1.59 1.28 1.23 1.01
Mpz
KLA  ATP  ATP+KLA
 NM_008623 myelin protein zero (Mpz), mRNA [NM_008623] KLA .97 1.01 .91 .98 1.07 1.02 1.12
ATP .98 .93 1.04 1.04 .99 1.04 1.07
KLA/ATP .98 1.04 1.01 1.00 1.01 .99 .98
Mpzl1
KLA  ATP  ATP+KLA
 NM_001001880 myelin protein zero-like 1 (Mpzl1), transcript variant 2, mRNA [NM_001001880] KLA .83 .78 .64 .64 .46 .36 .28
ATP .91 .91 1.22 1.08 1.81 3.00 .68
KLA/ATP .68 .73 .88 .74 1.47 3.65 .77
Ncam1
KLA  ATP  ATP+KLA
 NM_001113204 neural cell adhesion molecule 1 (Ncam1), transcript variant 3, mRNA [NM_001113204] KLA 1.02 1.03 1.01 1.00 .95 .94 1.01
ATP 1.02 .99 .98 1.07 .98 .97 1.03
KLA/ATP 1.02 .99 1.03 1.01 1.01 1.00 .99
Ncam1
KLA  ATP  ATP+KLA
 NM_010875 neural cell adhesion molecule 1 (Ncam1), transcript variant 2, mRNA [NM_010875] KLA 1.02 1.02 1.02 1.02 1.02 1.00 .99
ATP 1.02 1.03 1.01 1.00 1.01 1.00 1.00
KLA/ATP 1.04 1.05 1.05 1.02 1.00 .99 .98
Ncam2
KLA  ATP  ATP+KLA
 NM_010954 neural cell adhesion molecule 2 (Ncam2), transcript variant 2, mRNA [NM_010954] KLA 1.03 1.00 1.01 .97 1.03 1.00 .99
ATP .98 1.04 .99 1.02 1.01 1.01 1.05
KLA/ATP .98 1.01 1.06 .97 1.01 .95 1.00
Negr1
KLA  ATP  ATP+KLA
 NM_001039094 neuronal growth regulator 1 (Negr1), transcript variant 1, mRNA [NM_001039094] KLA .99 1.07 .91 1.07 1.03 .89 1.00
ATP 1.00 1.00 .93 .95 .96 .97 1.00
KLA/ATP 1.02 1.00 1.05 .93 .97 .91 .94
Negr1
KLA  ATP  ATP+KLA
 NM_177274 neuronal growth regulator 1 (Negr1), transcript variant 2, mRNA [NM_177274] KLA 1.01 1.00 .99 1.03 .99 1.03 1.03
ATP 1.05 1.01 .97 1.01 .99 1.01 1.01
KLA/ATP 1.03 1.00 .99 1.05 .98 1.02 .99
Neo1
KLA  ATP  ATP+KLA
 AK052439 13 days embryo lung cDNA, RIKEN full-length enriched library, clone:D430023D05 product:neogenin, full insert sequence. [AK052439] KLA 1.02 .96 .96 .98 1.01 1.03 1.01
ATP 1.01 1.00 1.04 1.03 .94 1.04 .99
KLA/ATP 1.02 1.05 1.11 1.03 .99 1.01 1.03
Neo1
KLA  ATP  ATP+KLA
 NM_008684 neogenin (Neo1), transcript variant 1, mRNA [NM_008684] KLA .83 .83 .78 .81 .74 .78 .84
ATP .99 1.01 1.06 .96 .98 1.26 1.42
KLA/ATP .83 .82 .82 .84 .84 .97 1.29
Nfasc
KLA  ATP  ATP+KLA
 NM_182716 neurofascin (Nfasc), mRNA [NM_182716] KLA 1.01 1.08 1.05 1.07 1.01 1.03 .99
ATP .94 1.00 1.06 1.01 1.00 1.00 1.03
KLA/ATP 1.01 1.09 1.13 1.08 1.08 1.08 1.01
Nlgn1
KLA  ATP  ATP+KLA
 AK083116 adult male hippocampus cDNA, RIKEN full-length enriched library, clone:C630015D03 product:SIMILAR TO NEUROLIGIN 1 homolog [Mus musculus], full insert sequence. [AK083116] KLA .99 .99 1.02 .94 .94 1.06 1.01
ATP .96 .93 1.06 .95 1.03 .97 1.06
KLA/ATP 1.06 1.07 1.00 .91 1.09 1.00 1.05
Nlgn1
KLA  ATP  ATP+KLA
 NM_138666 neuroligin 1 (Nlgn1), mRNA [NM_138666] KLA 1.06 1.03 1.02 1.04 1.00 1.00 .96
ATP 1.02 1.06 .92 .97 .97 .97 .97
KLA/ATP .97 1.01 1.03 1.04 .98 .96 .96
Nlgn2
KLA  ATP  ATP+KLA
 NM_198862 neuroligin 2 (Nlgn2), mRNA [NM_198862] KLA 2.93 2.71 3.55 3.01 3.30 2.11 .82
ATP 1.09 1.16 .98 1.25 2.33 4.95 2.38
KLA/ATP 2.82 3.31 3.16 5.14 8.54 8.76 3.69
Nlgn3
KLA  ATP  ATP+KLA
 NM_172932 neuroligin 3 (Nlgn3), mRNA [NM_172932] KLA 1.03 1.05 1.03 1.00 .98 1.08 1.02
ATP .98 .98 1.02 1.01 1.06 1.10 .97
KLA/ATP 1.06 .97 1.11 .93 1.00 1.07 1.07
Nrcam
KLA  ATP  ATP+KLA
 AK048567 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130076O07 product:hypothetical Immunoglobulin-like/Immunoglobulin C-2 type/Immunoglobulin subtype/Ig-like domain profile containing protein, full insert sequence. [AK048 KLA .40 .42 .53 .58 .55 .47 .38
ATP .80 .57 .64 .52 .56 .48 .40
KLA/ATP .39 .44 .53 .57 .63 .47 .37
Nrcam
KLA  ATP  ATP+KLA
 NM_176930 neuron-glia-CAM-related cell adhesion molecule (Nrcam), mRNA [NM_176930] KLA .59 .56 .52 .34 .22 .17 .14
ATP 1.12 .93 .94 .73 .60 .35 .19
KLA/ATP .62 .55 .50 .37 .30 .26 .15
Nrxn1
KLA  ATP  ATP+KLA
 NM_020252 neurexin I (Nrxn1), mRNA [NM_020252] KLA .99 .94 1.00 .98 .98 .97 1.06
ATP 1.02 1.02 .97 .99 1.00 .96 .97
KLA/ATP 1.02 .98 1.02 1.00 1.01 1.00 .99
Nrxn2
KLA  ATP  ATP+KLA
 NM_020253 neurexin II (Nrxn2), mRNA [NM_020253] KLA 1.15 1.20 1.26 1.26 1.20 1.17 1.13
ATP 1.03 1.05 1.13 1.21 1.24 1.12 1.12
KLA/ATP 1.21 1.18 1.41 1.40 1.42 1.29 1.14
Nrxn3
KLA  ATP  ATP+KLA
 NM_172544 neurexin III (Nrxn3), mRNA [NM_172544] KLA .99 1.01 1.00 .99 .97 1.04 .97
ATP 1.01 1.05 .98 1.01 .99 1.01 1.03
KLA/ATP 1.07 .99 .99 1.01 .98 1.01 1.05
Ntng1
KLA  ATP  ATP+KLA
 AK048796 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230070N18 product:netrin G1, full insert sequence. [AK048796] KLA 1.04 1.00 1.00 .98 1.05 .93 .97
ATP .98 1.04 1.14 .97 .93 .93 1.01
KLA/ATP .92 .99 1.10 1.03 .99 .98 .96
Ntng1
KLA  ATP  ATP+KLA
 NM_030699 netrin G1 (Ntng1), mRNA [NM_030699] KLA .92 .93 1.01 1.01 1.05 1.01 .93
ATP 1.03 1.01 .96 1.00 .99 .97 .98
KLA/ATP .96 1.02 .97 1.03 1.01 .98 .98
Ntng2
KLA  ATP  ATP+KLA
 AK011411 10 days embryo whole body cDNA, RIKEN full-length enriched library, clone:2610016D08 product:unclassifiable, full insert sequence. [AK011411] KLA 1.05 .95 1.05 1.03 1.04 1.00 1.08
ATP .98 1.06 1.04 1.03 .98 .93 .97
KLA/ATP 1.07 1.13 1.11 1.01 .94 .97 1.08
Ntng2
KLA  ATP  ATP+KLA
 NM_133500 netrin G2 (Ntng2), transcript variant a, mRNA [NM_133500] KLA 1.09 1.03 1.08 1.08 1.11 1.09 1.06
ATP 1.00 1.01 1.05 .98 1.02 1.20 1.00
KLA/ATP 1.00 1.03 1.07 1.14 1.12 1.06 1.18
Ocln
KLA  ATP  ATP+KLA
 NM_008756 occludin (Ocln), mRNA [NM_008756] KLA 1.02 1.04 1.03 1.03 .99 1.05 1.00
ATP 1.03 .98 1.01 1.07 1.05 1.05 1.04
KLA/ATP 1.09 1.00 1.03 1.05 1.06 1.03 1.01
Pdcd1
KLA  ATP  ATP+KLA
 NM_008798 programmed cell death 1 (Pdcd1), mRNA [NM_008798] KLA 1.31 1.46 1.48 1.45 1.46 1.24 1.11
ATP .99 1.04 1.12 1.11 1.02 .97 1.12
KLA/ATP 1.37 1.37 1.22 1.51 1.41 1.48 1.57
Pdcd1lg2
KLA  ATP  ATP+KLA
 NM_021396 programmed cell death 1 ligand 2 (Pdcd1lg2), mRNA [NM_021396] KLA 1.32 1.37 1.94 1.75 2.02 2.07 1.87
ATP 1.10 1.00 1.07 1.07 1.26 1.36 1.26
KLA/ATP 1.39 1.46 1.37 1.35 1.49 2.07 2.73
Pecam1
KLA  ATP  ATP+KLA
 AK031380 13 days embryo male testis cDNA, RIKEN full-length enriched library, clone:6030418F13 product:a disintegrin and metalloprotease domain 28, full insert sequence. [AK031380] KLA .95 1.06 1.09 1.02 1.03 .97 1.01
ATP .98 .96 1.04 1.09 1.01 1.04 .97
KLA/ATP 1.04 1.05 1.00 1.14 1.00 1.03 1.07
Pecam1
KLA  ATP  ATP+KLA
 NM_001032378 platelet/endothelial cell adhesion molecule 1 (Pecam1), transcript variant 2, mRNA [NM_001032378] KLA 1.29 1.31 1.58 1.50 1.94 2.18 1.90
ATP 1.03 1.04 1.05 1.22 1.20 1.11 1.19
KLA/ATP 1.30 1.24 1.28 1.63 1.49 1.62 2.13
Ptprc
KLA  ATP  ATP+KLA
 AK088215 2 days neonate thymus thymic cells cDNA, RIKEN full-length enriched library, clone:E430007G18 product:protein tyrosine phosphatase, receptor type, C, full insert sequence. [AK088215] KLA 2.15 1.93 2.11 1.83 2.08 1.72 1.51
ATP .95 .84 .65 .50 1.79 .82 .77
KLA/ATP 2.01 1.68 1.50 .80 1.16 .73 1.14
Ptprc
KLA  ATP  ATP+KLA
 NM_011210 protein tyrosine phosphatase, receptor type, C (Ptprc), transcript variant 2, mRNA [NM_011210] KLA 2.06 2.00 2.21 2.29 2.20 1.90 1.86
ATP 1.02 .99 1.23 .82 1.01 1.68 .86
KLA/ATP 1.89 2.00 2.40 1.52 1.24 1.01 1.20
Ptprf
KLA  ATP  ATP+KLA
 NM_011213 protein tyrosine phosphatase, receptor type, F (Ptprf), mRNA [NM_011213] KLA 1.28 1.42 1.29 1.27 1.17 1.19 1.27
ATP 1.09 1.11 1.27 1.29 1.53 2.24 2.95
KLA/ATP 1.31 1.42 1.28 1.33 1.25 1.50 1.60
Ptprm
KLA  ATP  ATP+KLA
 NM_008984 protein tyrosine phosphatase, receptor type, M (Ptprm), mRNA [NM_008984] KLA .99 1.08 1.01 1.15 1.02 1.26 5.69
ATP .99 1.01 1.05 .95 .96 .96 1.11
KLA/ATP .99 1.09 1.11 1.03 .95 1.04 1.29
Pvr
KLA  ATP  ATP+KLA
 NM_027514 poliovirus receptor (Pvr), mRNA [NM_027514] KLA 3.53 3.63 2.71 1.77 1.50 1.76 2.66
ATP .99 .95 1.51 2.53 5.08 4.56 2.00
KLA/ATP 3.65 2.92 1.84 1.82 4.02 5.37 3.39
Pvrl1
KLA  ATP  ATP+KLA
 NM_021424 poliovirus receptor-related 1 (Pvrl1), mRNA [NM_021424] KLA .69 .68 .57 .61 .46 .47 .49
ATP .97 .99 .94 .78 1.28 1.54 .89
KLA/ATP .70 .66 .69 .63 1.22 1.72 .81
Pvrl3
KLA  ATP  ATP+KLA
 NM_021495 poliovirus receptor-related 3 (Pvrl3), transcript variant alpha, mRNA [NM_021495] KLA 1.27 1.25 1.08 1.20 1.06 1.02 .88
ATP 1.05 .98 1.11 .97 1.01 1.44 1.24
KLA/ATP 1.23 1.32 1.23 1.17 1.16 1.43 1.15
Pvrl3
KLA  ATP  ATP+KLA
 NM_021496 poliovirus receptor-related 3 (Pvrl3), transcript variant beta, mRNA [NM_021496] KLA .99 1.00 1.12 1.00 1.05 .97 1.05
ATP 1.04 1.01 1.01 .98 1.02 1.06 1.05
KLA/ATP 1.04 1.06 1.09 1.03 1.01 1.06 1.00
Sdc1
KLA  ATP  ATP+KLA
 NM_011519 syndecan 1 (Sdc1), mRNA [NM_011519] KLA 1.40 1.34 1.52 1.50 1.64 2.31 2.39
ATP 1.20 1.20 1.28 2.62 10.61 16.35 9.95
KLA/ATP 1.61 1.71 1.60 3.94 11.52 15.28 20.29
Sdc2
KLA  ATP  ATP+KLA
 NM_008304 syndecan 2 (Sdc2), mRNA [NM_008304] KLA .93 1.00 .95 .89 .96 .93 .89
ATP 1.01 .98 .99 .99 .93 .96 .97
KLA/ATP .93 .91 1.05 .92 .92 .94 .89
Sdc3
KLA  ATP  ATP+KLA
 NM_011520 syndecan 3 (Sdc3), mRNA [NM_011520] KLA 1.06 1.04 1.21 1.12 1.34 1.84 2.18
ATP 1.02 1.17 .96 1.23 .97 .91 2.75
KLA/ATP 1.13 1.15 .98 1.30 .98 1.28 4.25
Sdc3
KLA  ATP  ATP+KLA
 U52826 syndecan-3 mRNA, complete cds. [U52826] KLA 1.29 1.30 1.42 1.39 1.56 2.13 2.33
ATP 1.08 1.20 1.11 1.36 1.02 1.09 3.13
KLA/ATP 1.40 1.38 1.32 1.50 1.07 1.41 4.29
Sdc4
KLA  ATP  ATP+KLA
 NM_011521 syndecan 4 (Sdc4), mRNA [NM_011521] KLA 11.43 12.18 10.95 10.65 8.99 5.55 1.88
ATP 1.01 1.13 1.24 3.44 3.56 2.85 2.00
KLA/ATP 11.15 13.40 11.98 16.31 11.68 6.11 4.76
Sele
KLA  ATP  ATP+KLA
 NM_011345 selectin, endothelial cell (Sele), mRNA [NM_011345] KLA 2.65 3.18 3.14 1.92 1.46 1.23 1.14
ATP .97 1.01 1.35 3.40 2.14 1.33 1.11
KLA/ATP 3.13 3.40 2.71 2.69 1.69 1.51 1.18
Sell
KLA  ATP  ATP+KLA
 NM_011346 selectin, lymphocyte (Sell), mRNA [NM_011346] KLA 2.94 3.69 4.84 5.31 5.76 7.52 5.69
ATP 1.05 1.15 1.35 1.48 1.27 2.02 2.52
KLA/ATP 3.11 3.42 4.21 3.51 3.01 5.34 10.40
Selp
KLA  ATP  ATP+KLA
 NM_011347 selectin, platelet (Selp), mRNA [NM_011347] KLA 1.34 1.37 1.61 1.53 1.59 1.28 1.06
ATP .98 1.00 1.07 1.10 1.11 1.68 1.10
KLA/ATP 1.37 1.45 1.44 1.34 1.22 1.37 1.46
Selplg
KLA  ATP  ATP+KLA
 NM_009151 selectin, platelet (p-selectin) ligand (Selplg), mRNA [NM_009151] KLA .98 1.02 1.18 1.25 1.68 1.74 1.24
ATP 1.17 1.26 .95 1.30 1.02 .72 1.21
KLA/ATP 1.06 1.15 .93 1.28 1.10 1.04 1.69
Siglec1
KLA  ATP  ATP+KLA
 NM_011426 sialic acid binding Ig-like lectin 1, sialoadhesin (Siglec1), mRNA [NM_011426] KLA 1.19 1.19 1.29 1.35 1.74 2.55 4.33
ATP 1.10 1.02 .90 .82 .66 .94 2.50
KLA/ATP 1.29 1.27 1.12 1.03 .76 1.22 5.21
Spn
KLA  ATP  ATP+KLA
 AK041480 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630014B01 product:sialophorin, full insert sequence. [AK041480] KLA .95 1.02 .97 1.05 1.02 1.06 1.02
ATP 1.05 .97 1.00 1.02 1.05 .97 1.00
KLA/ATP 1.03 .97 .89 1.05 1.05 1.06 .94
Spn
KLA  ATP  ATP+KLA
 NM_009259 sialophorin (Spn), transcript variant 1, mRNA [NM_009259] KLA .98 1.00 1.05 1.05 .96 .77 .38
ATP 1.06 .98 1.25 1.17 .91 .67 .22
KLA/ATP .95 .96 1.35 .96 .90 .52 .22
Vcam1
KLA  ATP  ATP+KLA
 NM_011693 vascular cell adhesion molecule 1 (Vcam1), mRNA [NM_011693] KLA 18.71 22.30 20.87 18.09 13.61 6.09 2.09
ATP 1.08 1.00 1.56 4.23 5.09 5.04 1.50
KLA/ATP 19.09 25.02 26.43 25.42 20.08 11.45 6.67
Vcan
KLA  ATP  ATP+KLA
 AK087780 2 days pregnant adult female ovary cDNA, RIKEN full-length enriched library, clone:E330020B03 product:unclassifiable, full insert sequence. [AK087780] KLA 1.19 1.13 1.30 1.22 1.18 1.18 1.14
ATP .98 .94 1.03 1.03 1.10 1.13 1.08
KLA/ATP 1.15 1.20 1.20 .99 1.09 1.17 1.11
Vcan
KLA  ATP  ATP+KLA
 NM_001081249 versican (Vcan), mRNA [NM_001081249] KLA 19.30 19.53 22.83 22.85 21.62 13.03 2.79
ATP 1.01 1.06 1.54 1.62 3.17 22.12 9.38
KLA/ATP 16.83 21.59 28.30 20.39 15.96 21.30 20.41
Vtcn1
KLA  ATP  ATP+KLA
 NM_178594 V-set domain containing T cell activation inhibitor 1 (Vtcn1), mRNA [NM_178594] KLA .97 .97 1.02 .97 .98 1.01 .94
ATP 1.04 1.02 .95 .97 1.01 1.02 1.02
KLA/ATP 1.01 .93 1.05 1.06 .97 1.00 1.08